Couto Bruna, Neves Celestino, Neves João Sérgio, Delgado Luís
Faculty of Medicine, University of Porto, Porto, Portugal.
Department of Endocrinology, Diabetes and Metabolism, ULS São João, Porto, Portugal.
BMC Endocr Disord. 2024 Dec 31;24(1):281. doi: 10.1186/s12902-024-01765-4.
Hashimoto's thyroiditis (HT) is associated with high cardiovascular risk. Thyroid volume has a notable dispersion of values in these patients. This study aims to clarify the association between thyroid antibodies, thyroid morphology, insulin resistance, and lipid profile in patients with HT.
Cross-sectional study that includes 409 subjects diagnosed with HT. We assessed thyroid function, markers of autoimmunity, and markers of cardiovascular risk. We also evaluated thyroid ultrasound and studied the correlation between all factors.
Among the study population, 9.8% were male, the mean age was 56.4 ± 17.4 years, 63.7% had dyslipidemia, and 29.5% had diabetes. Patients with hypothyroidism had higher levels of anti-thyroperoxidase antibodies (TPOab), and the decreased thyroid dimensions subgroup had a higher percentage of patients taking levothyroxine (98.7%). Positive correlations were found between TPOab and volume, and negative correlations were observed between thyroid-stimulating hormone (TSH) and volume.
The current study reveals a complex interrelationship between cardiovascular disease risk factors, thyroid function, autoimmunity, and thyroid volume in HT. These associations may be of clinical relevance, and further studies are needed to elucidate how these findings may be used clinically to reduce the cardiovascular risk in patients with HT.
桥本甲状腺炎(HT)与高心血管风险相关。在这些患者中,甲状腺体积的值存在显著差异。本研究旨在阐明HT患者甲状腺抗体、甲状腺形态、胰岛素抵抗和血脂谱之间的关联。
横断面研究,纳入409例诊断为HT的受试者。我们评估了甲状腺功能、自身免疫标志物和心血管风险标志物。我们还进行了甲状腺超声检查,并研究了所有因素之间的相关性。
在研究人群中,男性占9.8%,平均年龄为56.4±17.4岁,63.7%患有血脂异常,29.5%患有糖尿病。甲状腺功能减退患者的抗甲状腺过氧化物酶抗体(TPOab)水平较高,甲状腺尺寸减小亚组中服用左甲状腺素的患者比例较高(98.7%)。TPOab与体积呈正相关,促甲状腺激素(TSH)与体积呈负相关。
本研究揭示了HT患者心血管疾病风险因素、甲状腺功能、自身免疫和甲状腺体积之间存在复杂的相互关系。这些关联可能具有临床意义,需要进一步研究以阐明如何在临床上利用这些发现降低HT患者的心血管风险。